Agilisium's Rs 50 Crore AI Investment Revolutionizes Life Sciences

Agilisium, specializing in AI services for life sciences, has invested Rs 50 crore to enhance pharmaceutical, biotech, and medical tech companies' AI capabilities. This involves reskilling their workforce and implementing Forward Deployment Experts (FDX). The initiative focuses on embedding AI expertise within organizations for a sustainable transformation.

Life sciences AI service company Agilisium has invested Rs 50 crore in transforming pharmaceutical, biotech, and medical technology enterprises through operational AI, an executive announced on Wednesday.

Agilisium launched the Forward Deployment Experts (FDX) initiative, streamlining AI, technology, consultative solutions, and process thinking. This investment aims to reskill their global workforce, embedding AI capabilities within client organizations.

Founder and CEO Raj Babu emphasized that success in life sciences relies on integrating AI expertise. Agilisium is poised to lead the field through an embedded AI transformation model, combining extensive domain knowledge with advanced AI engineering and data capabilities.